Combinatorial and independent effects of exercise and myostatin/activin blocking on muscle gene expression profiling
Päivämäärä
2013The administration of soluble ligand binding domain of type IIb activin receptor fused
to the Fc domain (sActRIIB-Fc) has been recently shown to attenuate dystrophic
pathology and to increase muscle mass, but also to supress aerobic metabolism. In
contrast, aerobic exercise is known for promoting aerobic capacity. The aim of the
present thesis was to investigate the effects of the combination of myostatin/activin
blocking and aerobic exercise on muscle gene expression profile of a in Duchenne
Muscular Dystrophy (DMD) model, the mdx mouse. Microarray analysis was
conducted from the gastrocnemius muscle and Gene Set Enrichement Analysis (GSEA)
was performed to examine the effects of the treatments and muscle dystrophy on gene
sets and pathways. The level of significance was set at False Discovery Rate (FDR) <
0.05.
The results indicate that the beneficial effects of exercise in dystrophic muscle induce
transcription responses towards the gene expression profile of the healthy muscle.
Furthermore, the combination of exercise with myostatin/activin inhibition combines
the benefits of each intervention alone, without any obvious side effect. The most
profound changes were observed in aerobic metabolism pathways, where the shift in
gene expression is presented in many different pathways. Moreover, the elevated
expressions in glutathione and drug metabolism by cytochrome P450 pathways suggest
a possible role for oxidative damage in DMD pathology and increases in BCAAs
degradation and lipid metabolism indicate a possible connection between these two
processes, but further research is needed to explore the role of oxidative damage in
DMD pathology and their possible connections.
...
Metadata
Näytä kaikki kuvailutiedotKokoelmat
- Pro gradu -tutkielmat [29556]
Samankaltainen aineisto
Näytetään aineistoja, joilla on samankaltainen nimeke tai asiasanat.
-
Molecular and physiological effects of muscle wasting and its treatment by blocking myostatin and activins
Nissinen, Tuuli (Jyväskylän yliopisto, 2020)Muscle wasting, occurring e.g. in cancer, is associated with poor prognosis, and cancer treatments may even exacerbate the wasting. The prevention of muscle wasting has improved survival in preclinical cancer models, but ... -
Muscle follistatin gene delivery increases muscle protein synthesis independent of periodical physical inactivity and fasting
Nissinen, Tuuli A.; Hentilä, Jaakko; Fachada, Vasco; Lautaoja, Juulia H.; Pasternack, Arja; Ritvos, Olli; Kivelä, Riikka; Hulmi, Juha J. (John Wiley & Sons, 2021)Blocking of myostatin and activins effectively counteracts muscle atrophy. However, the potential interaction with physical inactivity and fasting in the regulation of muscle protein synthesis is poorly understood. We used ... -
Activin Receptor Ligand Blocking and Cancer Have Distinct Effects on Protein and Redox Homeostasis in Skeletal Muscle and Liver
Hentilä, Jaakko; Nissinen, Tuuli; Korkmaz, Ayhan; Lensu, Sanna; Silvennoinen, Mika; Pasternack, Arja; Ritvos, Olli; Atalay, Mustafa; Hulmi, Juha (Frontiers Research Foundation, 2019)Muscle wasting in cancer cachexia can be alleviated by blocking activin receptor type 2 (ACVR2) ligands through changes in protein synthesis/degradation. These changes in cellular and protein metabolism may alter protein ... -
Activin-A, myostatin and interleukin-6 in cancer associated cachexia
Härkönen, Jouni (2017)Cachexia is a muscle wasting condition associated with multiple different chronic illnesses, such as cancer, diabetes and AIDS. In cancer, approximately 80% of patients with advanced disease have symptoms of muscle wasting, ... -
An attempt to enhance neurogenesis of mdx mice via aerobic exercise and myostatin inhibition
Ylikulju, Teemu (2013)Duchennen lihasdystrofia (DMD) on perinnöllinen sairaus, jonka esiintyvyys on noin 1/3600 poikavauvasta. Siihen liittyy lihasten heikkoutta, rappeutumista ja kognitiivista vajavaisuutta. Taudin aiheuttaa mutatoitunut geeni ...
Ellei toisin mainittu, julkisesti saatavilla olevia JYX-metatietoja (poislukien tiivistelmät) saa vapaasti uudelleenkäyttää CC0-lisenssillä.